These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001. Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE. Clin Infect Dis; 2004 Jun 15; 38(12):1780-3. PubMed ID: 15227627 [Abstract] [Full Text] [Related]
7. Rubella vaccination related to immunological status. Morrison A, Whitmore M, Edmond E. Health Bull (Edinb); 1977 Jul 15; 35(4):192-6. PubMed ID: 903223 [No Abstract] [Full Text] [Related]
8. The riddle of fuchs heterochromic uveitis. Rothova A. Am J Ophthalmol; 2007 Sep 15; 144(3):447-8. PubMed ID: 17765425 [No Abstract] [Full Text] [Related]
9. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E, Tischer A. Gesundheitswesen; 1993 Jan 15; 55(1):38-9. PubMed ID: 8435543 [Abstract] [Full Text] [Related]
10. Elimination of rubella and congenital rubella syndrome--United States, 1969-2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2005 Mar 25; 54(11):279-82. PubMed ID: 15788995 [Abstract] [Full Text] [Related]
11. [Prevention of congenital rubella]. Vesikari T, Vaheri A. Duodecim; 1974 Mar 25; 90(16):1081-3. PubMed ID: 4410487 [No Abstract] [Full Text] [Related]
12. Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Birnbaum AD, Tessler HH, Schultz KL, Farber MD, Gao W, Lin P, Oh F, Goldstein DA. Am J Ophthalmol; 2007 Sep 25; 144(3):424-428. PubMed ID: 17631266 [Abstract] [Full Text] [Related]
13. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC, Burgess MA, O'Brien ED. Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
14. Economic evaluation of different vaccination programmes to prevent congenital rubella. Stray-Pedersen B. NIPH Ann; 1982 Dec 06; 5(2):69-83. PubMed ID: 6820478 [Abstract] [Full Text] [Related]
15. Re: Factors associated with low immunity to rubella infection on antenatal screening. Francis B, Thomas A, Haverkamp M. Aust N Z J Obstet Gynaecol; 2006 Apr 06; 46(2):172. PubMed ID: 16638048 [No Abstract] [Full Text] [Related]
16. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S. J Clin Virol; 2005 Oct 06; 34(2):153-4. PubMed ID: 16076562 [Abstract] [Full Text] [Related]
17. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C. Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798 [Abstract] [Full Text] [Related]
18. [Vaccination against mumps and vaccination against rubella]. Just M. Ther Umsch; 1983 Mar 10; 40(3):212-5. PubMed ID: 6857560 [No Abstract] [Full Text] [Related]
19. [Preventive rubella vaccination for risk groups]. Hülsse C, Reincke E, Scholz B, Müller I, Pathenheimer F. Z Gesamte Hyg; 1987 Jul 10; 33(7):330-2. PubMed ID: 3660873 [No Abstract] [Full Text] [Related]
20. Vaccination against rubella. Br Med J; 1972 Feb 05; 1(5796):375. PubMed ID: 5008673 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]